U.S. President Donald Trump announced that TrumpRx.gov will now offer more than 600 generic prescription drugs, significantly expanding the administration’s effort to lower medication costs for Americans. The government-backed platform, originally launched in January with branded medicines only, will now include widely used generic drugs such as atorvastatin for cholesterol treatment and metformin for diabetes management.
Trump revealed the expansion during a White House event attended by billionaire entrepreneur Mark Cuban, whose Cost Plus Drugs online pharmacy is partnering in the initiative. According to the administration, the update increases the number of medicines available on TrumpRx by nearly seven times.
TrumpRx does not directly sell medications. Instead, the website connects consumers to pharmacy providers offering discounted prescription drug prices. The platform will integrate pricing information and savings options from Amazon Pharmacy, Cost Plus Drugs, GoodRx, and local pharmacies, helping users compare affordable medication prices in one place.
The White House stated that generic medicines will be listed separately from discounted high-cost branded drugs. However, controlled substances and medications subject to FDA risk evaluation and mitigation strategies (REMS) will not be available through the service.
The Trump administration said the expansion is part of its broader “most-favored-nation” pricing strategy, which aims to align U.S. prescription drug prices with those paid in other developed countries. Trump previously secured agreements with 17 major pharmaceutical companies, offering temporary tariff exemptions in exchange for lower drug pricing commitments.
Officials estimate the policy could generate more than $64 billion in federal and state savings over the next decade. Still, questions remain about how much consumers will personally save, especially since purchases made through TrumpRx are generally intended for uninsured buyers and may not count toward insurance deductibles.
According to the U.S. Food and Drug Administration, more than 90% of medications sold in the United States are generic drugs, making the TrumpRx expansion a major step toward broader access to affordable healthcare.


Marco Rubio to Visit Iceland, Greece and Portugal
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Nike Stock Slides as Revenue Miss Clouds Turnaround
Circle Urges EU to Revise MiCA Stablecoin Rules
Japan Protests to US After Marine Arrested in Okinawa Murder Case
Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal
Ukraine Deploys FP-7 Ballistic Missile in Combat for First Time
Coinbase, Circle Stocks Slide as Bank Group Sues OCC Over Crypto Charters
US Waives Egypt Military Aid Conditions Over Iran War Role
Netanyahu Vows Probe Into Foiled Flydubai Crash Attempt
Iran Faces Rising Pressure as U.S. Builds Military Presence
Trump Heads to Ohio to Boost Husted in Tight Senate Race
Revolut Challenges Europe’s Banking Giants as Global Growth Accelerates
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Amazon Eyes $8 Billion Nvidia Chip Spinoff to Fund AI Expansion
Robinhood Stock Nears $114 as Jobs Data Boosts Risk Appetite
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 



